(Q37676926)

21 August 2017

1 reference

title

Disease-associated functions of IL-33: the new kid in the IL-1 family (English)

1 reference

21 August 2017

Iain B McInnes

3

0 references

author name string

Foo Y Liew

series ordinal

1

1 reference

PubMed ID

20081870

21 August 2017

Nick I Pitman

series ordinal

2

1 reference

21 August 2017

18 January 2010

1 reference

Nature Reviews Immunology

21 August 2017

1 reference

21 August 2017

10

1 reference

21 August 2017

2

1 reference

21 August 2017

103-110

1 reference

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

21 August 2017

1 reference

A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor

31 March 2020

1 reference

Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells

31 March 2020

1 reference

T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function

31 March 2020

1 reference

Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses.

31 March 2020

1 reference

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

31 March 2020

1 reference

The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?

31 March 2020

1 reference

IL-33 reduces the development of atherosclerosis

31 March 2020

1 reference

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

31 March 2020

1 reference

Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules

31 March 2020

1 reference

Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket

31 March 2020

1 reference

The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1

31 March 2020

1 reference

Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases.

31 March 2020

1 reference

Interleukin-33 is biologically active independently of caspase-1 cleavage

31 March 2020

1 reference

Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes

31 March 2020

1 reference

Mature interleukin-33 is produced by calpain-mediated cleavage in vivo

31 March 2020

1 reference

Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1 alpha released from dying cells

31 March 2020

1 reference

Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis

31 March 2020

1 reference

HMGB1: endogenous danger signaling

31 March 2020

1 reference

Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein

31 March 2020

1 reference

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

31 March 2020

1 reference

Alarmins: chemotactic activators of immune responses

31 March 2020

1 reference

DAMPs, PAMPs and alarmins: all we need to know about danger

31 March 2020

1 reference

The cytokine interleukin-33 mediates anaphylactic shock

31 March 2020

1 reference

IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex

31 March 2020

1 reference

IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells

31 March 2020

1 reference

TRAF6 is a critical signal transducer in IL-33 signaling pathway

31 March 2020

1 reference

Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells

31 March 2020

1 reference

Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells

31 March 2020

1 reference

IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4.

31 March 2020

1 reference

IL-1, IL-18, and IL-33 families of cytokines

31 March 2020

1 reference

IL-33 can promote survival, adhesion and cytokine production in human mast cells

31 March 2020

1 reference

IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals

31 March 2020

1 reference

Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation

31 March 2020

1 reference

IL-33 is a chemoattractant for human Th2 cells.

31 March 2020

1 reference

IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.

31 March 2020

1 reference

The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production.

31 March 2020

1 reference

An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor

31 March 2020

1 reference

IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation

31 March 2020

1 reference

A novel IL-1 family cytokine, IL-33, potently activates human eosinophils

31 March 2020

1 reference

Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils

31 March 2020

1 reference

IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex

31 March 2020

1 reference

IL-33-activated dendritic cells induce an atypical TH2-type response

31 March 2020

1 reference

IL-33, a potent inducer of adaptive immunity to intestinal nematodes

31 March 2020

1 reference

Inhibition of T1/ST2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2)- but not Th1-driven immunopathology

31 March 2020

1 reference

Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells

31 March 2020

1 reference

Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway

31 March 2020

1 reference

Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system

31 March 2020

1 reference

Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma

31 March 2020

1 reference

The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function

31 March 2020

1 reference

T1/ST2 expression on Th2 cells negatively regulates allergic pulmonary inflammation

31 March 2020

1 reference

Mast cells modulate allergic pulmonary eosinophilia in mice

31 March 2020

1 reference

Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction

31 March 2020

1 reference

Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction

31 March 2020

1 reference

Identification of serum soluble ST2 receptor as a novel heart failure biomarker

31 March 2020

1 reference

The effect of ST2 gene product on anchorage-independent growth of a glioblastoma cell line, T98G.

31 March 2020

1 reference

Induction of IL-33 expression and activity in central nervous system glia

31 March 2020

1 reference

Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage

31 March 2020

1 reference

Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease

31 March 2020

1 reference

IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice

31 March 2020

1 reference

IL-33 exacerbates antigen-induced arthritis by activating mast cells

31 March 2020

1 reference

Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis

31 March 2020

1 reference

Induction of a mitogen-responsive gene after expression of the Ha-ras oncogene in NIH 3T3 fibroblasts

31 March 2020

1 reference

Tissue Distribution and Subcellular Localization of a Variant Form of the Human ST2 Gene Product, ST2V

31 March 2020

1 reference

Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1.

31 March 2020

1 reference

A novel therapy of murine collagen-induced arthritis with soluble T1/ST2.

31 March 2020

1 reference

Elevation of ST2 protein levels in cerebrospinal fluid following subarachnoid hemorrhage

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20081870

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Role of cell type-specific promoters in the developmental regulation of T1, an interleukin 1 receptor homologue.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20081870

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identification of a nuclear localization sequence within the structure of the human interleukin-1 alpha precursor.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20081870

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRI2692

1 reference

21 August 2017

1 reference

PubMed ID

20081870